Craniomaxillofacial is a special branch of orthopedic surgery, which focuses on all the aspects of facial and skull disorders. The craniomaxillofacial implant surgery is carried out to treat a severe injury of facial and cranial bones, where the implants are temporarily or permanently placed in the body. Traumas, accidents, and genetic defects lead to craniomaxillofacial deformities.
Craniomaxillofacial implants is revolutionizing the healthcare industry by providing improved treatment options for facial and cranial injuries or any craniomaxillofacial abnormalities. 3D printing technology is also enabling manufacturers to provide customized implants according to the requirement of patients, which makes the market more attractive. Road accidents are considered to be the common reason for most of the craniomaxillofacial injuries. Increased incidence of facial fractures is expected to propel the global craniomaxillofacial market.
Ask For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/773
Craniomaxillofacial implants offer benefits such as customization based on the requirement of patient with the help of newly advanced 3D printing technology. Furthermore, growing prevalence of facial injuries is also expected to favor the growth of craniomaxillofacial implants. Emerging techniques for facial and cranial surgical procedures with higher success rate will also promote the use of craniomaxillofacial implants throughout the forecast period. Introduction of robotic arm assisted craniomaxillofacial surgery makes the surgery safer and efficient.
Key features of the study:
This report provides an in-depth analysis of global craniomaxillofacial implants in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global craniomaxillofacial implants for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.
Patient specific implants, 3D implants, growing demand for bioresorbable materials, and growing adoption of robot assisted surgeries have simplified the complexity of craniomaxillofacial surgeries. Whereas, advanced techniques, including computer-assisted craniofacial reconstruction, distraction osteogenesis, and endoscopic procedures, combined with refinements in surgical equipment such as resorbable plating and distractors, have improved surgical outcomes, while minimizing morbidity. The development of bone graft substitutes with the help of gene therapy and nanotechnology is also expected to drive the craniomaxillofacial implants market. Click To Read More On Craniomaxillofacial Implants Market